Search
for
Sort by
Research 421–450 of 1000+
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- The usefulness and wellbeing of Tofacitinib in the treatment of Alopecia Areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- Common Causes of Hair Loss
- P100: Efficacy of current treatments under study in patients with alopecia areata
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- DataSheet2_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Acne exacerbation after tofacitinib treatment for alopecia areata
- The changing landscape of managing hair loss: a 30‐year perspective
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Alopecia areata
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- Medical Therapies
- In reply
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Hair today, gone tomorrow
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older